CellaVision AB (publ) (OTCMKTS:CLVSF) Short Interest Up 90.8% in July

CellaVision AB (publ) (OTCMKTS:CLVSF) was the target of a significant increase in short interest in the month of July. As of July 15th, there was short interest totaling 38,369 shares, an increase of 90.8% from the June 30th total of 20,112 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is currently ∞ days.

CellaVision AB (publ) Price Performance

CLVSF stock opened at $14.00 on Friday. CellaVision AB has a twelve month low of $13.49 and a twelve month high of $17.30. The business’s 50-day simple moving average is $13.71 and its 200 day simple moving average is $15.01.

CellaVision AB (publ) Company Profile

CellaVision AB (publ), headquartered in Lund, Sweden, is a developer and manufacturer of advanced digital cell morphology solutions for clinical laboratories. The company’s systems automate the preparation, imaging and classification of blood and body fluid slides, enabling laboratory professionals to optimize workflow and improve diagnostic accuracy. CellaVision’s platform is designed to support a broad range of hematology analyses, including white blood cell differentiation, red blood cell morphology assessment and platelet evaluation.

The company’s core offering revolves around its digital microscopy instruments and proprietary software.